BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31415041)

  • 1. Ceftriaxone Reduced Susceptible Neisseria gonorrhoeae in the Netherlands, 2009 to 2017: From PenA Mosaicism to A501T/V Nonmosaicism.
    de Laat MM; Wind CM; Bruisten SM; Dierdorp M; de Vries HJC; Schim van der Loeff MF; van Dam AP
    Sex Transm Dis; 2019 Sep; 46(9):594-601. PubMed ID: 31415041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015.
    Wind CM; Bruisten SM; Schim van der Loeff MF; Dierdorp M; de Vries HJC; van Dam AP
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373191
    [No Abstract]   [Full Text] [Related]  

  • 3. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.
    Liang JY; Cao WL; Li XD; Bi C; Yang RD; Liang YH; Li P; Ye XD; Chen XX; Zhang XB
    BMC Infect Dis; 2016 Apr; 16():152. PubMed ID: 27080231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined mutations of the penA with ftsX genes contribute to ceftriaxone resistance in Neisseria gonorrhoeae and peptide nucleic acids targeting these genes reverse ceftriaxone resistance.
    Zhu L; Liang J; Zheng Y; Chen S; Xu Q; Yin S; Hong Y; Cao W; Lai W; Gong Z
    J Glob Antimicrob Resist; 2023 Dec; 35():19-25. PubMed ID: 37567469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
    Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
    BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.
    Heymans R; Bruisten SM; Golparian D; Unemo M; de Vries HJ; van Dam AP
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1516-22. PubMed ID: 22214779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.
    Chen SC; Yin YP; Dai XQ; Unemo M; Chen XS
    J Antimicrob Chemother; 2016 Jan; 71(1):92-9. PubMed ID: 26472770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A real-time PCR assay for detecting a penA mutation associated with ceftriaxone resistance in Neisseria gonorrhoeae.
    Shimuta K; Igawa G; Yasuda M; Deguchi T; Nakayama SI; Ohnishi M
    J Glob Antimicrob Resist; 2019 Dec; 19():46-49. PubMed ID: 30825697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    de Korne-Elenbaas J; Bruisten SM; de Vries HJC; Van Dam AP
    J Antimicrob Chemother; 2021 Jun; 76(7):1759-1768. PubMed ID: 33739419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.
    Serra-Pladevall J; Barberá MJ; Rodriguez S; Bartolomé-Comas R; Roig G; Juvé R; Andreu A
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1549-56. PubMed ID: 27255221
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Vincent LR; Kerr SR; Tan Y; Tomberg J; Raterman EL; Dunning Hotopp JC; Unemo M; Nicholas RA; Jerse AE
    mBio; 2018 Apr; 9(2):. PubMed ID: 29615507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
    Lee SG; Lee H; Jeong SH; Yong D; Chung GT; Lee YS; Chong Y; Lee K
    J Antimicrob Chemother; 2010 Apr; 65(4):669-75. PubMed ID: 20093260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination and genome analysis of high-level ceftriaxone-resistant
    Lin X; Chen W; Xie Q; Yu Y; Liao Y; Feng Z; Qin X; Wu X; Tang S; Zheng H
    Emerg Microbes Infect; 2022 Dec; 11(1):344-350. PubMed ID: 34994305
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular epidemiology of Neisseria gonorrhoeae strains circulating in Indonesia using multi-locus variable number tandem repeat analysis (MLVA) and Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) techniques.
    Hananta IPY; van Dam AP; Schim van der Loeff MF; Dierdorp M; Wind CM; Soebono H; de Vries HJC; Bruisten SM
    BMC Infect Dis; 2018 Jan; 18(1):7. PubMed ID: 29304758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
    Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
    J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.
    Hess D; Wu A; Golparian D; Esmaili S; Pandori W; Sena E; Klausner JD; Barry P; Unemo M; Pandori M
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5633-41. PubMed ID: 22908152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
    Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
    Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.